Free Trial

Genus plc (LON:GNS) Insider Sells £345,628.77 in Stock

Genus logo with Medical background
Remove Ads

Genus plc (LON:GNS - Get Free Report) insider Jorgen Kokke sold 19,967 shares of Genus stock in a transaction dated Friday, February 28th. The stock was sold at an average price of GBX 1,731 ($22.00), for a total value of £345,628.77 ($439,228.33).

Genus Stock Up 1.8 %

LON:GNS traded up GBX 32.28 ($0.41) during trading hours on Tuesday, hitting GBX 1,872.28 ($23.79). 318,908 shares of the stock traded hands, compared to its average volume of 140,591. Genus plc has a fifty-two week low of GBX 1,424 ($18.10) and a fifty-two week high of GBX 2,155 ($27.39). The firm has a market cap of £1.23 billion, a price-to-earnings ratio of 155.20, a PEG ratio of 2.87 and a beta of 0.37. The company has a current ratio of 1.80, a quick ratio of 1.08 and a debt-to-equity ratio of 53.12. The firm has a 50 day moving average price of GBX 1,715.47 and a 200 day moving average price of GBX 1,799.09.

Genus (LON:GNS - Get Free Report) last posted its quarterly earnings results on Thursday, February 27th. The company reported GBX 39.80 ($0.51) EPS for the quarter. Genus had a net margin of 1.18% and a return on equity of 1.41%. Equities research analysts anticipate that Genus plc will post 70.9644323 earnings per share for the current year.

Analyst Ratings Changes

Separately, Shore Capital reissued a "buy" rating on shares of Genus in a research note on Wednesday, December 11th.

Read Our Latest Analysis on Genus

Genus Company Profile

(Get Free Report)

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand.

Recommended Stories

Should You Invest $1,000 in Genus Right Now?

Before you consider Genus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genus wasn't on the list.

While Genus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Time to Buy SoFi? Fintech’s Next Big Move
3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?
Why Palantir’s Future Just Got a Massive Boost

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads